Fevertree Drinks (FEVR) Rating Reiterated by Morgan Stanley

Fevertree Drinks (LON:FEVR)‘s stock had its “overweight” rating reaffirmed by investment analysts at Morgan Stanley in a research report issued to clients and investors on Tuesday. They currently have a GBX 3,100 ($42.83) target price on the stock. Morgan Stanley’s target price indicates a potential upside of 10.44% from the company’s previous close.

FEVR has been the subject of several other research reports. Shore Capital reaffirmed a “hold” rating on shares of Fevertree Drinks in a research report on Tuesday. Jefferies Group started coverage on shares of Fevertree Drinks in a research report on Friday, January 19th. They set a “buy” rating and a GBX 3,000 ($41.45) price target for the company. Investec reiterated a “buy” rating and set a GBX 2,330 ($32.19) price objective on shares of Fevertree Drinks in a research note on Tuesday, December 5th. Finally, Berenberg Bank reiterated a “buy” rating and set a GBX 2,400 ($33.16) price objective on shares of Fevertree Drinks in a research note on Monday, November 20th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of GBX 2,488.33 ($34.38).

Shares of Fevertree Drinks (FEVR) traded up GBX 212 ($2.93) during mid-day trading on Tuesday, reaching GBX 2,807 ($38.78). 828,886 shares of the company traded hands, compared to its average volume of 429,823. Fevertree Drinks has a 1 year low of GBX 1,353.93 ($18.71) and a 1 year high of GBX 2,888.15 ($39.90). The firm has a market capitalization of $3,240.00 and a price-to-earnings ratio of 7,197.44.

In other news, insider Andrew Branchflower sold 26,905 shares of the company’s stock in a transaction on Tuesday, March 13th. The shares were sold at an average price of GBX 2,596 ($35.87), for a total value of £698,453.80 ($964,981.76).

ILLEGAL ACTIVITY NOTICE: This story was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2018/03/14/fevertree-drinks-fevr-rating-reiterated-by-morgan-stanley.html.

About Fevertree Drinks

Fevertree Drinks plc is a United Kingdom-based holding and investment company. The Company is a developer and supplier of premium mixer drinks. The Company’s premium mixers consist of a range of all natural carbonated mixers, including Tonics, Ginger Ale, Ginger Beer, Bitter Lemon and Lemonades. The Company sells a range of products under the Fever-Tree brand, which include Indian Tonic Water, Naturally Light Tonic Water, Elderflower Tonic Water, Mediterranean Tonic Water, Ginger Ale, Ginger Beer, Naturally Light Ginger Beer, Bitter Lemon, Sicilian Lemonade, Lemonade, Spring Soda Water and Premium Cola.

Analyst Recommendations for Fevertree Drinks (LON:FEVR)

Receive News & Ratings for Fevertree Drinks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fevertree Drinks and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply